Clinical features of this enteropathy include gastrointestinal symptoms such as diarrhea, weight loss and steatorrhea, negative IgA tissue transglutaminase antibodies (or endomysial-antibodies), evidence of enteropathy (villous atrophy) with or without collagen deposition or intraepithelial lymphocytes, lack of clinical response to a gluten-free diet, and exclusion of other causes of enteropathy [18]. This evidence concerns the gene CD79A and Abnormal intestine morphology.